Catalyst Biosciences (CBIO) EPS Estimated At $-5.25, Anglo Asian Mining Plc (LON:AAZ) Covered By 1 Bullish Analysts Last Week

July 17, 2017 - By sdlfksdklf klsdf

Analysts expect Catalyst Biosciences Inc (NASDAQ:CBIO) to report $-5.25 EPS on August, 3 before the open.They anticipate $1.05 EPS change or 16.67% from last quarter’s $-6.3 EPS. After having $-4.57 EPS previously, Catalyst Biosciences Inc’s analysts see 14.88% EPS growth. About 60,532 shares traded. Catalyst Biosciences Inc (NASDAQ:CBIO) has declined 80.67% since July 17, 2016 and is downtrending. It has underperformed by 97.37% the S&P500.

Among 2 analysts covering Anglo Asian Mining PLC (LON:AAZ), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Anglo Asian Mining PLC had 18 analyst reports since September 22, 2015 according to SRatingsIntel. The rating was maintained by SP Angel with “Buy” on Friday, September 16. The stock of Anglo Asian Mining Plc (LON:AAZ) has “Speculative Buy” rating given on Thursday, April 14 by Beaufort Securities. The company was maintained on Friday, December 23 by SP Angel. The stock of Anglo Asian Mining Plc (LON:AAZ) earned “Hold” rating by SP Angel on Tuesday, September 22. The stock has “Hold” rating by SP Angel on Wednesday, October 14. The stock of Anglo Asian Mining Plc (LON:AAZ) earned “Speculative Buy” rating by Beaufort Securities on Wednesday, September 23. SP Angel maintained it with “Buy” rating and GBX 25 target in Monday, October 17 report. SP Angel maintained the shares of AAZ in report on Thursday, January 14 with “Hold” rating. SP Angel maintained Anglo Asian Mining Plc (LON:AAZ) on Monday, September 12 with “Buy” rating. SP Angel maintained Anglo Asian Mining Plc (LON:AAZ) on Wednesday, November 11 with “Hold” rating. See Anglo Asian Mining Plc (LON:AAZ) latest ratings:

Catalyst Biosciences, Inc., formerly Targacept, Inc., is a clinical-stage biopharmaceutical company. The company has market cap of $19.61 million. The Firm is focused on creating and developing medicines to address serious medical conditions. It currently has negative earnings. The Firm focuses its product development efforts in the fields of hemostasis, including the treatment of hemophilia and surgical bleeding, and inflammation, including prevention of delayed graft function in renal transplants and the treatment of dry age-related macular degeneration (dry AMD), a condition that can cause visual impairment or blindness.

Anglo Asian Mining PLC is a United Kingdom based holding company. The company has market cap of 20.31 million GBP. The Firm is a well-known provider of support and management services to its operating subsidiary R.V. It has a 6.61 P/E ratio. Investment Group Services LLC .

The stock decreased 1.37% or GBX 0.25 on July 17, reaching GBX 18. About shares traded. Anglo Asian Mining Plc (LON:AAZ) has 0.00% since July 17, 2016 and is . It has underperformed by 16.70% the S&P500.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>